Viking Therapeutics (VKTX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist

34.940
+0.890+2.61%

Close Jan 23 16:00 ET

35.179
+0.239+0.68%

Post 18:58 ET

3.89BMarket Cap-37.17P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Allurion Stock Soars 70% on Weight-loss Therapy Update
Seeking Alpha52minutes ago
Viking Therapeutics (VKTX) Stock Could Rise 200%, Says Jefferies
TipRanks11:28 ET
Jefferies Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $110
Moomoo NewsJan 23 08:31 ET · Ratings
Viking Therapeutics: Strategic Growth and Strong Buy Rating Amidst Advancements in Obesity Drug Pipeline
TipRanksJan 23 08:16 ET · Ratings
This Weight-Loss Drug Stock Could Gain 200%. The Case for It to Challenge Novo, Lilly. -- Barrons.com
Barron'sJan 23 07:38 ET
BTIG Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $125
Moomoo NewsJan 23 06:31 ET · Ratings

Comments

Justin Teeburd

8 hours ago

$Viking Therapeutics (VKTX.US)$

10xStockPicks

10 hours ago

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...